Skip to content

Clinical trials

Phase 2 Pleural Effusion trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion Phase: Phase 2 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20081
20092
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Beth Israel Deaconess Medical Center1
CanBas Co. Ltd.1
National Heart, Lung, and Blood Institute (NHLBI)1
Rein Therapeutics1
University of Kansas1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion7
Lung Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Ascites1
Chylothorax1
Chylous Ascites1
Lymphangioleiomyomatosis1
Lymphangiomyoma1
Neoplasm Metastasis1
Pleural Effusion, Malignant1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.